CHYRISSA STALEY: Open Payments
NPI 1346597663 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 32 payments from 9 companies in 2025. Trend: 2023 $1,155 · 2024 $1,166 · 2025 $1,864
Food & beverage: $1,864
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $1,207 |
| Boston Scientific Corporation | 8 | $436 |
| Globus Medical, Inc. | 2 | $63 |
| Saluda Medical Americas, Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| SPR Therapeutics, Inc | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
Products named: ETERNA, Intracept, PROCLAIM, Intracept RF Probe, IONICRF, Senza, Evoke, RELISTOR.
Industry payments across TX — which companies pay providers there.
